ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. — Stella

Recruiting

Back to Psoriasis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey

Key details

Phase

Post-approval study

Sponsor

Psoriasis Treatment Center of Central New Jersey

Collaborators

Sun Pharmaceutical Industries Limited

Enrollment target

~25 participants

Started

April 2020

Primary completion

December 2020

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2020

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov